Turkish Adaptation of the VascuQoL-6 Quality of Life Scale (NCT06979245) | Clinical Trial Compass
CompletedNot Applicable
Turkish Adaptation of the VascuQoL-6 Quality of Life Scale
Turkey (Türkiye)37 participantsStarted 2025-03-01
Plain-language summary
Study type: Observational study Primary objective: The aim of this study was to examine the validity and reliability of the Vascular Quality of Life Questionnaire-6 (VascuQoL-6) in Turkish in individuals diagnosed with Takayasu Arteritis or Vascular Behçet's disease.
The main questions it aims to answer are:
Can VascuQoL-6 measure disease-related quality of life validly and reliably? Does the scale show significant correlations with measures such as SF-36, EQ-5D-3L, BDCAF, BSAS and ITAS-2010? There is no comparison group.
Participants will be asked to:
Contribute to the translation process of the scale into Turkish, Complete all quality of life forms in the first assessment, Participate in the test-retest analysis by re-filling VascuQoL-6 one week later.
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Being between the ages of 18-65
* Being willing to participate in the study
* Being diagnosed with Takayasu Arteritis or Vascular Behçet's disease by a rheumatologist
Exclusion Criteria:
* Having another disease that will affect their physical condition
* Having a cognitive disability that will prevent them from cooperating
* Being pregnant
* Having a neurological disease (hemiplegia, Parkinson's, multiple sclerosis, vertigo, epilepsy, etc.)
* Having undergone any surgery in the last year
* Having another simultaneous rheumatic disease
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Since this trial was focused on adapting a quality-of-life questionnaire into Turkish rather than testing a treatment, how might the VascuQoL-6 tool actually be used in managing my condition like Takayasu Arteritis or Behcet Disease going forward?
2Now that this study is completed, does my care team currently use the Turkish version of the VascuQoL-6 to measure how my vascular disease is affecting my daily life, and if not, are there similar tools being used in my care?
3Because this was a validation study rather than a treatment trial, what does my doctor think are the next steps in research for improving quality of life in patients with Takayasu Arteritis or Behcet Disease?
4Could the findings from a study like this one influence how my symptoms and quality of life are formally tracked during my treatment, and would that change any decisions about my care?
5Are there any active treatment trials for my condition that use quality-of-life measures like the VascuQoL-6 as an outcome, where participation might be worth discussing??
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.